Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Spectral AI, Inc. (MDAI)

Spectral AI Names Darcy Bajko Chief Commercial Officer, Effective July 31, 2026

Neutral Impact 4 of 5 leadership Written later

Spectral AI appointed Darcy Bajko as Chief Commercial Officer, effective July 31, 2026, to lead commercial functions for the global launch of its FDA-cleared DeepView System for burn indication. The filing sets her base salary at $315,000 and grants options on 150,000 shares, which adds a senior commercial executive and related compensation cost for shareholders.

Key points

  • Darcy Bajko, previously Vice President of Commercialization and Customer Success at MediView XR, starts July 31, 2026.
  • Base salary of $315,000, with a target bonus of up to 30% of base salary tied to milestones and performance goals.
  • Stock options for 150,000 common shares under the 2023 Long Term Incentive Plan, vesting annually over three years; options fully vest upon a change of control.
  • The company's CEO said the first commercial sales of DeepView are targeted by year end 2026.

The filing

CompanySpectral AI, Inc. (MDAI)
Form8-K, current report
Filed with the SECJul 8, 2026, 4:01 PM ET
Accession number0001213900-26-076349

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 08, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.